Higher LP(a), CRP Levels Associated with Higher Risk of MACE, Analysis Shows
A prespecified secondary analysis of the ACCELERATE trial shows that elevated levels of lipoprotein(a), or LP(a), and high-sensitivity C-reactive protein (hsCRP) >2mg/l are related to risk of cardiovascular death, myocardial infarction and stroke.